Hughes David
Programme complémentaire en Analyse et evaluation des interventions en santé, Université de Montréal, Montréal, QC.
Can J Public Health. 2010 May-Jun;101(3):193-5. doi: 10.1007/BF03404372.
Among all categories of health expenditure in Canada, spending on drugs is the fastest growing. The factors at play in the increase in expenditure on drugs are essentially those related to the volume of use and the arrival of new drugs on the market. Some of these new drugs are very expensive. In fact, the costs of certain drugs threaten the continued existence of the Québec Prescription Drug Insurance Plan. In Québec, the Conseil du médicament (Drug Board) is responsible for recommending drugs to the Ministry of Health and Social Services to be put on the formulary of drugs covered by the public plan. In spite of pressure by various stakeholders, we believe that the rationing of drugs that are too expensive can achieve political legitimacy if it is based on a transparent justification that includes not only evidence-based criteria, but also ethical principles and values. For egalitarians, fairness in the supply of health care should be accomplished as a function of health care needs. But this concept of justice should also be extended to future generations. The balance of current and future needs should be achieved by determining what would be "reasonable access" through public consultations among experts and citizens.
在加拿大所有类别的医疗支出中,药品支出增长最快。药品支出增加的影响因素主要与使用量以及新药进入市场有关。其中一些新药非常昂贵。事实上,某些药品的成本威胁到魁北克处方药保险计划的持续存在。在魁北克,药品委员会负责向卫生和社会服务部推荐药品,以便列入公共计划覆盖的药品目录。尽管受到各利益相关方的压力,但我们认为,如果对过于昂贵的药品进行配给基于透明的理由,包括不仅基于循证标准,还包括伦理原则和价值观,那么这种配给就能获得政治合法性。对于平等主义者来说,医疗保健供应的公平性应根据医疗保健需求来实现。但这种正义概念也应扩展到子孙后代。当前和未来需求的平衡应通过专家和公民之间的公众协商来确定什么是“合理获取”来实现。